7-OXO-PGI2 EPHEDRIDINE SALTS

The invention relates to new 7-oxo-PGI2-ephedrine salt analogues of the Formula I wherein A stands for -(CH2)2-, cis or trans -CH=CH- or -C 3BOND C-; R1 is lower alkyl or hydrogen; B represents a chemical bond, -CH2- or -CR2R3; R2 stands for lower alkyl or hydrogen; R3 represents lower alkyl or hydr...

Full description

Saved in:
Bibliographic Details
Main Authors PAL HADHAZY, GYORGY DORMAN, PETER GYORY, KAROLY KANAI, GEZA GALAMBOS, GABOR KOVACS, GYULA PAPP, JENO MARTON, LASZLO SZEKERES, ISTVAN STADLER, EVA UDVARY, ISTVAN TOMOSKOZI, PETER KORMOCZY
Format Patent
LanguageEnglish
Published 21.09.1989
Edition4
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to new 7-oxo-PGI2-ephedrine salt analogues of the Formula I wherein A stands for -(CH2)2-, cis or trans -CH=CH- or -C 3BOND C-; R1 is lower alkyl or hydrogen; B represents a chemical bond, -CH2- or -CR2R3; R2 stands for lower alkyl or hydrogen; R3 represents lower alkyl or hydrogen; X is a chemical bond, -O- or -CH2-; R4 stands for C1-6 alkyl, C4-7 cycloalkyl, C1-6 fluoroalkyl, C2-6 alkenyl, C2-6 alkynyl, phenyl, substituted phenyl or heteroaryl. The salts of the Formula I show the same pharmacological profile as the sodium salt of PGI2, they inhibit blood aggregation and the secretion of gastric acid, are useful in the prevention of anginal attacks. Accordingly the salts of the present invention are useful in the prevention of peripheral vascular diseases, in improving circulation of extremities, in relieving the seriousness of cardiac infarction and also in the treatment and prevention of gastrointestinal ulcer and acute or chronical liver injury.
Bibliography:Application Number: AU19860058001